Literature DB >> 27853868

Immune function monitoring in lung transplantation using adenosine triphosphate production: time trends and relationship to postoperative infection.

Mamoru Takahashi1, Akihiro Ohsumi1, Keiji Ohata1, Takeshi Kondo1, Hideki Motoyama1, Kyoko Hijiya1, Akihiro Aoyama1, Hiroshi Date1, Toyofumi F Chen-Yoshikawa2.   

Abstract

PURPOSE: The ImmuKnow (IK) assay is a comprehensive immune function test that involves measuring adenosine triphosphate produced by the cluster of differentiation 4+ T lymphocytes in peripheral blood. The aim of this study was to analyze the time trends of IK values and assess the relationship between IK values and infections in lung transplants.
METHODS: We prospectively collected 178 blood samples from 22 deceased-donor lung transplant (DDLT) recipients and 17 living-donor lobar lung transplant (LDLLT) recipients. A surveillance IK assay was performed postoperatively, then after 1 week and 1, 3, 6, and 12 months.
RESULTS: Time trends of IK values in stable recipients peaked 1 week after DDLT (477 ± 247 ATP ng/ml), and 1 month after LDLLT (433 ± 134 ng/ml), followed by a gradual decline over 1 year. The mean IK values in infections were significantly lower than those in the stable state (119 vs 312 ATP ng/ml, p = 0.0002).
CONCLUSIONS: IK values increased sharply after lung transplantation and then decreased gradually over time in the first year, suggesting a natural history of immune function. IK values were also significantly reduced during infections. These results may provide new insights into the utility of immune monitoring after lung transplantation.

Entities:  

Keywords:  Adenosine triphosphate production; Immune function test; Lung transplantation; Postoperative infections

Mesh:

Substances:

Year:  2016        PMID: 27853868     DOI: 10.1007/s00595-016-1440-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  25 in total

1.  Antibody-mediated rejection of a unilateral donor lung in bilateral living-donor lobar lung transplantation: report of a case.

Authors:  Fengshi Chen; Naomi Chibana; Akihiro Kanematsu; Shunji Takakura; Kimiko Yurugi; Rie Hishida; Atushi Fukatsu; Takeshi Kubo; Tsuyoshi Shoji; Takuji Fujinaga; Toru Bando; Hiroshi Date
Journal:  Surg Today       Date:  2012-02-28       Impact factor: 2.549

Review 2.  ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis.

Authors:  Emilio Rodrigo; Marcos López-Hoyos; Mario Corral; Emilio Fábrega; Gema Fernández-Fresnedo; David San Segundo; Celestino Piñera; Manuel Arias
Journal:  Liver Transpl       Date:  2012-10       Impact factor: 5.799

3.  Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes.

Authors:  Jon A Kobashigawa; Krista K Kiyosaki; Jignesh K Patel; Michelle M Kittleson; Bernard M Kubak; Stephanie N Davis; Matt A Kawano; Abbas A Ardehali
Journal:  J Heart Lung Transplant       Date:  2010-02-04       Impact factor: 10.247

4.  The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012.

Authors:  Jason D Christie; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Anne I Dipchand; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Josef Stehlik; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2012-10       Impact factor: 10.247

5.  Less maintenance immunosuppression in lung transplantation following hematopoietic stem cell transplantation from the same living donor.

Authors:  F Chen; M Yamane; M Inoue; T Shiraishi; T Oto; M Minami; J Yanagisawa; T Fujinaga; T Shoji; S Toyooka; M Okumura; S Miyoshi; T Bando; H Date
Journal:  Am J Transplant       Date:  2011-06-14       Impact factor: 8.086

6.  Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management.

Authors:  Richard Kowalski; Diane Post; Mary C Schneider; Judith Britz; Judy Thomas; Mark Deierhoi; Andrew Lobashevsky; Robert Redfield; Eugene Schweitzer; Alonso Heredia; Elise Reardon; Charles Davis; Carol Bentlejewski; John Fung; Ron Shapiro; Adriana Zeevi
Journal:  Clin Transplant       Date:  2003-04       Impact factor: 2.863

7.  Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group.

Authors:  J F Neylan
Journal:  Transplantation       Date:  1998-02-27       Impact factor: 4.939

8.  Establishing pediatric immune response zones using the Cylex ImmuKnow assay.

Authors:  E Hooper; D M Hawkins; R J Kowalski; D R Post; J A Britz; K C Brooks; M A Turman
Journal:  Clin Transplant       Date:  2005-12       Impact factor: 2.863

9.  Unilateral chronic lung allograft dysfunction is a characteristic of bilateral living-donor lobar lung transplantation.

Authors:  Ei Miyamoto; Fengshi Chen; Akihiro Aoyama; Masaaki Sato; Tetsu Yamada; Hiroshi Date
Journal:  Eur J Cardiothorac Surg       Date:  2014-12-02       Impact factor: 4.191

10.  Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients.

Authors:  Valerie B Sampson; Stephen P Dunn; Beth Rymeski; James Malatack; Nancy H Rong; Louise Flynn; Leslie J Krueger
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545

View more
  2 in total

1.  Effect of Immunosuppression on Target Blood Immune Cells Within 1 Year After Lung Transplantation: Influence of Age on T Lymphocytes.

Authors:  Benjamin Coiffard; Matthieu Pelardy; Anderson D Loundou; Corine Nicolino-Brunet; Pascal Alexandre Thomas; Laurent Papazian; Françoise Dignat-George; Martine Reynaud-Gaubert
Journal:  Ann Transplant       Date:  2018-01-05       Impact factor: 1.530

Review 2.  Individualizing immunosuppression in lung transplantation.

Authors:  Jennifer K McDermott; Reda E Girgis
Journal:  Glob Cardiol Sci Pract       Date:  2018-03-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.